Mary Crowley Cancer Research, a 501(c)3 nonprofit, provides personalized, innovative clinical trials to advanced cancer patients using the newest gene-targeted and immune therapies. Founded by Dallas entrepreneur Mary Crowley in 1992, Mary Crowley Cancer Research has operated in compliance with the FDA for over 23 years. Mary Crowley Cancer Research: Hope Lives Here.